SCHEMBL4778037

SCHEMBL4778037

CCOCc1nc2c(cnn2CC)c(-c2cncc(C)c2)c1C=O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 3/20 0.32
MAPT P10636 2/20 0.32
TSHR P16473 2/20 0.32
NPSR1 Q6W5P4 2/20 0.32
RECQL P46063 1/20 0.32
SIGMAR1 Q99720 1/20 0.32
MEN1 O00255 1/20 0.32
GMNN O75496 1/20 0.32
USP2 O75604 1/20 0.32
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
TP53 P04637 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
MAPK1 P28482 1/20 0.32
CYP2C19 P33261 1/20 0.32
THPO P40225 1/20 0.32
BLM P54132 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4776059 0.91 PDE10A (0.33) PDE10AMAPTTSHRNPSR1RECQL
SCHEMBL4769535 0.89 PSEN1 (0.32) MAPTTSHRNPSR1RECQLSIGMAR1
SCHEMBL4772879 0.89 SIGMAR1 (0.34) PDE10AMAPTTSHRNPSR1RECQL
SCHEMBL4778372 0.88 MAPT (0.32) PDE10AMAPTTSHRNPSR1RECQL
SCHEMBL4772397 0.87 MEN1 (0.33) PDE10AMAPTTSHRNPSR1MEN1
SCHEMBL4772412 0.87 MEN1 (0.33) PDE10AMAPTTSHRNPSR1MEN1
SCHEMBL4776510 0.87 SIGMAR1 (0.33) PDE10AMAPTTSHRNPSR1RECQL
SCHEMBL4771686 0.86 PDE1A (0.35) MAPTTSHRNPSR1RECQLSIGMAR1
SCHEMBL4778711 0.86 MEN1 (0.35) PDE10AMAPTTSHRNPSR1SIGMAR1
SCHEMBL4778517 0.85 SIGMAR1 (0.32) SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7459451-B2 e.g. 1-Ethyl-4-(5-methyl-3-pyridyl)-6-phenyl-1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid; phosphodiesterase (PDE)-IV inhibitor or tumor necrosis factor (TNF)- alpha antagonist; autoimmune diseases, antidepressant, anxiolytic agent; polychondritis, scleroderma, fibrosis, arthritis, Alzheimer's disease ASTELLAS PHARMA INC. (JP) 2008-12-02 US disclosed
EP-1763528-B1 PYRAZOLOPYRIDINE DERIVATIVES ASTELLAS PHARMA INC (JP) 2008-11-26 EP disclosed
EP-1763528-A1 PYRAZOLOPYRIDINE DERIVATIVES Astellas Pharma Inc. (JP) 2007-03-21 EP disclosed
WO-2006004188-A1 PYRAZOLOPYRIDINE DERIVATIVES ASTELLAS PHARMA INC. (JP) 2006-01-12 WO disclosed